The Autologous CaTeVac Dendritic Cell Vaccine in Patients With Melanoma: Final Results of the DENDRON-01 Study. Вопр. онкол. 2025, 71 (4), OF-2437. https://doi.org/10.37469/0507-3758-2025-71-4-OF-2437.